SCHEMBL8963754

SCHEMBL8963754

COc1ccccc1-c1nc(CN2CCN(C(c3ccccc3)c3ccccc3)CC2)c(C)[nH]1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.53
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
DRD2 P14416 3/20 0.46
DRD3 P35462 3/20 0.46
DRD4 P21917 2/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
CYP3A4 P08684 3/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41
CHRM2 P08172 2/20 0.41
ADORA3 P0DMS8 2/20 0.41
CHRM1 P11229 2/20 0.41
ADRA2C P18825 2/20 0.41
CNR1 P21554 2/20 0.41
SLC6A2 P23975 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8963659 0.89 MAPT (0.52) MAPTMEN1KMT2ADRD2DRD3
SCHEMBL8963541 0.87 DRD2 (0.49) MAPTMEN1KMT2ADRD2DRD3
SCHEMBL8963948 0.85 DRD3 (0.47) MAPTMEN1KMT2ADRD2DRD3
SCHEMBL9424936 0.85 MAPT (0.53) MAPTMEN1KMT2ADRD2DRD3
SCHEMBL8963668 0.83 DRD2 (0.64) MAPTMEN1KMT2ADRD2DRD3
SCHEMBL8964060 0.83 DRD2 (0.53) MAPTMEN1KMT2ADRD2DRD3
SCHEMBL8969984 0.83 LMNA (0.47) MAPTMEN1KMT2ADRD2DRD3
Hydrochloric Acid SCHEMBL8963587 0.81 KMT2A (0.49) MAPTMEN1KMT2ADRD2ALDH1A1
SCHEMBL8963551 0.81 DRD2 (0.51) MAPTMEN1KMT2ADRD2DRD3
Lifarizine SCHEMBL676318 0.81 DRD2 (0.57) MAPTMEN1KMT2ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed
US-5252736-A Calcium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1993-10-12 US disclosed
EP-0289227-B1 SUBSTITUTED IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES SYNTEX PHARMACEUTICALS LTD. (GB) 1992-04-08 EP disclosed
US-5091428-A Calcium channel blockers preferential for cerebral blood vessels SYNTEX PHARMACEUTICALS, LTD. (BM) 1992-02-25 US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 US disclosed
US-5010075-A Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent SYNTEX PHARMACEUTICALS LTD. (GB) 1991-04-23 US disclosed
US-4935417-A CALCIUM CHANNEL BLOCKERS SYNTEX PHARMACEUTICALS LTD. (BM) 1990-06-19 US disclosed
US-4829065-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1989-05-09 US disclosed
EP-0289227-A1 Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS LTD. (GB) 1988-11-02 EP disclosed